Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Neotec
2. Tc-99m Depreotide
3. Technetium Tc 99m Depreotide
1. Neotect
2. Technetium Tc 99m Depreotide
3. Technetium Tc-99m Depreotide
4. 9m48m2sf02
5. 174900-52-8
6. Unii-9m48m2sf02
7. Neotec
8. Tc-99m Depreotide
9. Technetium Tc 99m Depreotide [who-dd]
10. Technetium Tc 99m Depreotide [usp Impurity]
11. Technetium Tc-99m Depreotide [orange Book]
12. Q27272728
13. Technetium-99tc, (cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl) (1-1')-thioether With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamidato(3-))oxo-, (sp-5-24)-
14. Technetium-99tc, (cyclo(l-homocysteinyl-n-methyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl)(1-1')-sulfide With 3-((mercaptoacetyl)amino)-l-alanyl-l-lysyl-l-cysteinyl-l-lysinamidato(3-))oxo-, (sp-5-24)-
| Molecular Weight | 1454.6 g/mol |
|---|---|
| Molecular Formula | C65H96N16O12S2Tc |
| Hydrogen Bond Donor Count | 17 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 34 |
| Exact Mass | 1453.58987 g/mol |
| Monoisotopic Mass | 1453.58987 g/mol |
| Topological Polar Surface Area | 492 Ų |
| Heavy Atom Count | 96 |
| Formal Charge | 0 |
| Complexity | 2490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
This medicinal product is for diagnostic use only.
For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, in
combination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.
V09IA05
ABOUT THIS PAGE
A Technetium Tc 99M Depreotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Technetium Tc 99M Depreotide, including repackagers and relabelers. The FDA regulates Technetium Tc 99M Depreotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Technetium Tc 99M Depreotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Technetium Tc 99M Depreotide supplier is an individual or a company that provides Technetium Tc 99M Depreotide active pharmaceutical ingredient (API) or Technetium Tc 99M Depreotide finished formulations upon request. The Technetium Tc 99M Depreotide suppliers may include Technetium Tc 99M Depreotide API manufacturers, exporters, distributors and traders.
Technetium Tc 99M Depreotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Technetium Tc 99M Depreotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Technetium Tc 99M Depreotide GMP manufacturer or Technetium Tc 99M Depreotide GMP API supplier for your needs.
A Technetium Tc 99M Depreotide CoA (Certificate of Analysis) is a formal document that attests to Technetium Tc 99M Depreotide's compliance with Technetium Tc 99M Depreotide specifications and serves as a tool for batch-level quality control.
Technetium Tc 99M Depreotide CoA mostly includes findings from lab analyses of a specific batch. For each Technetium Tc 99M Depreotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Technetium Tc 99M Depreotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Technetium Tc 99M Depreotide EP), Technetium Tc 99M Depreotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Technetium Tc 99M Depreotide USP).
LOOKING FOR A SUPPLIER?
